United Therapeutics Corp (NASDAQ:UTHR)

CAPS Rating: 3 out of 5

A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases.

Recs

0
Player Avatar TerryHoodSr (< 20) Submitted: 10/2/2012 5:52:52 PM : Outperform Start Price: $57.98 UTHR Score: -19.10

2013 EPS 5.30, TP 67

Featured Broker Partners


Advertisement